Oligoclonal selection of nanobodies targeting vascular endothelial growth factor
While monoclonal antibodies are efficient therapeutics for cancer treatment, nanobodies or variable heavy domain – due to their small size, high stability, and solubility – have many advantages in comparison. Oligoclonal nanobodies are a mixture of nanobodies against different epitopes of an antigen...
Furkejuvvon:
| Váldodahkkit: | , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Taylor & Francis Group
2019-01-01
|
| Ráidu: | Journal of Immunotoxicology |
| Fáttát: | |
| Liŋkkat: | http://dx.doi.org/10.1080/1547691X.2018.1526234 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|